According to InfuSystem's latest financial reports and stock price the company's current Operating Margin is 1.71%. At the end of 2021 the company had an Operating Margin of 1.23%.
Year | Operating Margin | Change |
---|---|---|
2021 | 1.23% | -84.15% |
2020 | 7.75% | 312.24% |
2019 | 1.88% | -221.06% |
2018 | -1.55% | -79.02% |
2017 | -7.40% | 1332.45% |
2016 | -0.52% | -106.68% |
2015 | 7.73% | -17.27% |
2014 | 9.34% | 115.45% |
2013 | 4.34% | -218.51% |
2012 | -3.66% | -97.09% |
2011 | -125.51% | 1739.25% |
2010 | -6.82% | -251.85% |
2009 | 4.49% | -85.35% |
2008 | 30.68% | -219.78% |
2007 | -25.62% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Premier PINC | 20.90% | 1,122.22% | ๐บ๐ธ USA |
![]() DexCom DXCM | 13.43% | 685.38% | ๐บ๐ธ USA |
![]() CorVel Corporation
CRVL | 12.12% | 608.77% | ๐บ๐ธ USA |
![]() Biolase
BIOL | -41.06% | -2,501.17% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.